2 Feb 2012 okklo life sciences is entering a collaboration with UMC Radboud (Nijmegen, The Netherlands) for the development of novel therapeutic approaches against multi-drug resistant tuberculosis (MRD-TB). Resistance against treatment with antibiotics is increasingly common in many infectious diseases, and this also is a serious health issue concern …
